OrthoPreserve
orthopreserve.com
Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
New York Angels
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 4, 2025
Took on debt financing $157k · SEC Form D
Oct 16, 2024
Took on debt financing $50k · SEC Form D
2021
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Debt Financing | Dec 2025 | $157k | — | SEC Form D |
| Debt Financing | Oct 2024 | $50k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | OrthoPreserve, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Jonathan SchwartzExecutive Officer, DirectorSEC Form D
Cyrus KumpExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
New York Angels Similar startupsby what they do, their industry and backers
TRANSFORM THE TREATMENT OF RHEUMATOID ARTHRITIS. The convergence of extraordinary advances in immunology, neuroscience, and engineering…
VisiPlate by Avisi Technologies is an investigational implant designed to lower intraocular pressure in patients with open-angle glaucoma.
About VarmX OUR MISSION To revolutionize the treatment of severe bleeding through a fast, safe, and effective medicine VarmX's VMX-C001 is…
COMPANY Now is the time for surgical therapeutics Peptilogics is a clinical stage company advancing its lead engineered peptide, zaloganan…
Suffering from tendonitis? Learn how TendoNova's innovative treatment helps plantar fasciitis, tennis elbow, golfer's elbow, Achilles…
Quercis Pharma develops Kinisoquin™, a first-in-class oral PDI inhibitor in Phase 3 for the prevention of cancer-associated thrombosis…
Overview
Developing a meniscus implant for the treatment of persistent knee pain and prevention of arthritis in patients with prior meniscus injury.
People
Jonathan Schwartz
Executive Officer, Director
Cyrus Kump
Executive Officer, Director
David Guillot
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data